COMMUNIQUÉS West-GlobeNewswire

Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

28/02/2019 - 22:30

MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2018 financial results after the market closes on Thursday, [...]

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results

28/02/2019 - 22:24

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]

Adverum to Present at the Cowen 39th Annual Health Care Conference

28/02/2019 - 22:10

MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the [...]

Aravive to Report Fourth Quarter and Full Year 2018 Financial Results and Corporate Updates on March 7, 2019

28/02/2019 - 22:10

HOUSTON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced the company plans to report financial results for the fourth quarter and full year 2018 and [...]

CymaBay Reports Fourth Quarter and Fiscal Year End 2018 Financial Results and Provides Corporate Update

28/02/2019 - 22:05

Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY) a clinical-stage biopharmaceutical company focused on developing therapies for [...]

ICU Medical, Inc. Announces Fourth Quarter 2018 Results

28/02/2019 - 22:05

SAN CLEMENTE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

SI-BONE to Present at the Canaccord Genuity Musculoskeletal Conference

28/02/2019 - 22:05

SANTA CLARA, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse [...]

Fulgent Genetics Reports Fourth Quarter and Full Year 2018 Financial Results

28/02/2019 - 22:05

Fourth Quarter 2018 Results : Revenue totals $5.7 million, growing 33% year over year Billable tests delivered total 6,408, growing 52% year over year GAAP loss of $935,000, or $0.05 per share Non-GAAP loss of $193,000 [...]

Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results

28/02/2019 - 22:05

TYMLOS® U.S. net sales continued to increase, reaching $34.4 million in the fourth quarter of 2018 and totaling $99.2 million for full-year 2018, exceeding the Company’s guidance of $95-98 million. Elacestrant’s Phase 3 [...]

KemPharm Reports Q4 and FY 2018 Results

28/02/2019 - 22:05

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Completed KP415 clinical and human abuse potential programs Received approval [...]

HealthEquity Sets Date to Announce Year-end Results

28/02/2019 - 22:04

Attend Investor Conference DRAPER, Utah, Feb. 28, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced that it plans to [...]

Mersana Therapeutics Announces Proposed Public Offering of Common Stock

28/02/2019 - 22:03

CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

28/02/2019 - 22:02

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance

28/02/2019 - 22:02

-Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. ( [...]

March is #ChildrensWishMonth - Help Grant More Heartfelt Wishes

28/02/2019 - 22:01

Donate today at ChildrensWish.ca/WishMonth TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Children’s Wish Foundation of Canada, the largest and only all-Canadian wish-granting charity, is kicking off #ChildrensWishMonth [...]

En mars, faites-les rêver! Participez au #MoisRevesdenfants et aidez encore plus d’enfants malades à réaliser leur plus grand rêve

28/02/2019 - 22:01

Faites un don à revesdenfants.ca/Moisrevesdenfants . MONTRÉAL, 28 févr. 2019 (GLOBE NEWSWIRE) -- La Fondation Rêves d’enfants, le plus grand et le seul organisme de bienfaisance entièrement canadien dédié à la [...]

Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results

28/02/2019 - 22:01

Record Fourth Quarter & Full Year 2018 Algovita® Sales of $14.1 million and $47.1 million, Up 36% and 84% YoY Respectively PLANO, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a [...]

Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update

28/02/2019 - 22:01

Conference Call Scheduled for Friday, March 1 at 8:30am Eastern Time REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix Pharmaceuticals” or the “ [...]

G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results

28/02/2019 - 22:01

Reported positive findings in all four randomized Phase 2 clinical trials of trilaciclib in 2018 Clinical program updates to be provided at Investor Day 2019 on March 6 Management to host webcast and conference call [...]